These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35211549)

  • 21. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
    Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
    Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
    Chen L; Zhu X; Li D; Cai X
    J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety profile of combining programmed cell death-1 (PD-1) inhibitors and antiangiogenic targeting agents as subsequent therapy for advanced or metastatic non-small cell lung cancer (NSCLC).
    Xu Z; Li T; Hu X; Hao X; Xing P; Li J
    Thorac Cancer; 2021 Sep; 12(17):2360-2368. PubMed ID: 34268872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer.
    Zhou ZT; Zhou FX; Wei Q; Zou LY; Qin BF; Peng XS
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):1027-32. PubMed ID: 21327933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
    Pan G; Ke S; Zhao J
    Target Oncol; 2013 Jun; 8(2):107-16. PubMed ID: 23516098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial.
    Zhang R; Wang ZY; Li YH; Lu YH; Wang S; Yu WX; Zhao H
    Lancet; 2016 Oct; 388 Suppl 1():S95. PubMed ID: 27968915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.
    Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
    Cancer Chemother Pharmacol; 1992; 31(2):81-4. PubMed ID: 1280537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
    Wang J; Sun Y; Liu Y; Yu Q; Zhang Y; Li K; Zhu Y; Zhou Q; Hou M; Guan Z; Li W; Zhuang W; Wang D; Liang H; Qin F; Lu H; Liu X; Sun H; Zhang Y; Wang J; Luo S; Yang R; Tu Y; Wang X; Song S; Zhou J; You L; Wang J; Yao C
    Zhongguo Fei Ai Za Zhi; 2005 Aug; 8(4):283-90. PubMed ID: 21108883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI].
    Fan Y; Huang ZY; Yu HF; Luo LH
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):859-63. PubMed ID: 21223694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
    Lu S; Li L; Luo Y; Zhang L; Wu G; Chen Z; Huang C; Guo S; Zhang Y; Song X; Yu Y; Zhou C; Li W; Liao M; Li B; Xu L; Chen P; Hu C; Hu C
    J Thorac Oncol; 2015 Jan; 10(1):206-11. PubMed ID: 25654728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endostatin combined with platinum-based chemo-radiotherapy for advanced non-small cell lung cancer.
    Jiang X; Guan W; Li M; Liang W; Qing Y; Dai N; Zhang S; Deng Y; Meng H; Yang Y; Zhong Z
    Cell Biochem Biophys; 2015 Mar; 71(2):571-7. PubMed ID: 25209742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Weekly Paclitaxel and Cisplatin in the Treatment of Elderly Advanced Non-small Cell Lung Cancer.].
    Liang Y; Chen L; Lin Y; Yang Q; Wang Z; Xu G
    Zhongguo Fei Ai Za Zhi; 2009 Oct; 12(10):1101-5. PubMed ID: 20723350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study.
    Liu Y; Dong Y; Zhu H; Jing W; Guo H; Yu J
    Cancer Med; 2020 Feb; 9(4):1365-1373. PubMed ID: 31876976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical report of combined chemotherapy with gemcitabine plus cisplatin as first-line treatment to 79 cases of advanced non-small cell lung cancer].
    Lin L; Hao X; Li J; Wang Z; Wang Y; Wang H; Hu X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2007 Dec; 10(6):513-9. PubMed ID: 21129311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Yuan M; Zhai Y; Men Y; Wang J; Deng L; Wang W; Bao Y; Yang X; Sun S; Ma Z; Liu Y; Wang J; Zhu H; Hui Z
    Thorac Cancer; 2021 Dec; 12(23):3208-3215. PubMed ID: 34676669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.
    Arrieta O; Barrón F; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; Díaz-García D; Yamamoto Ramos M; Mota-Vega B; Carmona A; Peralta Álvarez MP; Bautista Y; Aldaco F; Gerson R; Rolfo C; Rosell R
    JAMA Oncol; 2020 Jun; 6(6):856-864. PubMed ID: 32271354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancer.
    Mori K; Saito Y; Tominaga K
    Am J Clin Oncol; 1992 Aug; 15(4):344-7. PubMed ID: 1325109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and Safety of Bevacizumab Combined with Chemotherapy as Second-line or Later-line Treatment in Advanced Nonsquamous Non-small Cell Lung Cancer].
    Zheng X; Wang H; Zhang G; Yan X; Ma Z
    Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):513-518. PubMed ID: 30037370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy.
    Liu W; Zhang J; Ying C; Wang Q; Yan C; Jingyue Y; Zhaocai Y; Yan X; Heng-Jun S; Lin J
    Int J Biomed Sci; 2012 Mar; 8(1):28-35. PubMed ID: 23675254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer.
    Liu ZJ; Wang J; Wei XY; Chen P; Wang LC; Lin L; Sun BC; Li K
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):927-37. PubMed ID: 22331237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.